There may have been a lot of people in the room looking at all sides of health care reform through different colored glasses, but there was one central message no matter their position.
Clement Cypra, deputy vice president for State Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), summed it up when he said, “Everybody knew that some fundamental changes had to be made and it was waiting for a political solution.”
And even though federal health care reform provided that solution—or at...